Great find re Dr Max's linkedin post, mighty, and I liked the follow-up comment from Adeel Shahid, a radiologist at Houston Methodist hospital. He had this to say about Leronlimab's ability to convert PD-L1–negative tumors to PD-L1–positive:

"Interesting. If reproducible prospectively in larger studies, wouldn’t this be an earthquake across all of solid tumor oncology? Excellent work"

---

I like the sound of "earthquake across all solid tumor oncology."